LINC02060

Across TCGA pan-cancer cohorts, LINC02060 RNA differs between tumor and matched normal tissue in 4 of 18 cancer types tested, making tumor–normal expression one of LINC02060’s most consistent transcriptional readouts.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where LINC02060 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types LINC02060 is over-expressed in tumor, although a few such as ESCA show the opposite, repressed pattern.

KIRC, THCA, and ESCA are the cancer types where LINC02060 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in LINC02060 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
KIRC	Female	All	+0.111	.008	4	view →
THCA	All	All	+0.059	.004	2	view →
ESCA	All	All	−0.240	.011	1	view →
CHOL	All	All	+0.071	.024	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 4 strongest of 4 lineages.

LINC02060–KIRC

Open the KIRC breakdown →